Jeff Beck & The Who To Play Charity Gig

Legends set for KILLING Cancer charity show in London in January

The Who and Jeff Beck will play at a cancer charity concert in January.

The rock legends will play A Concert For KILLING Cancer at the Hammersmith Apollo in London on 13 January where they will be joined by Blondie’s Debbie Harry and former Verve frontman Richard Ashcroft.

The concert will raise money for the KILLING Cancer charity that funds research into a little-known therapy that destroys cancer cells with a single treatment – without patients suffering the emotional and physical trauma of chemotherapy and radiotherapy.

Photodynamic Therapy (PDT) works by light combining with a drug that switches off the oxygen reaching the target cells and is a fraction of the cost of current cancer treatments.

Despite this, PDT is rarely offered to patients and the gig will highlight the availability of this cutting edge therapy.

The idea for the concert came from legendary promoter Harvey Goldsmith and Bill Curbishley, manager of The Who and Robert Plant.

"Robert and I had lived through the final months and days of close friends battling with cancer,” says Bill Curbishley, "but also fighting to overcome the effects of their treatments. Only later we discovered that PDT could perhaps have saved their lives – and certainly given them some dignity in their final weeks.”

Concert impresario, Harvey Goldsmith, says that of all his charity projects, this one for KILLING Cancer has a special significance. "I lost my mother to cancer in the past 12 months. I saw how she struggled but finally lost the fight to beat her cancer. People often say that the treatment is worse than the cancer.

"I have seen how PDT is a much more gentle treatment and the funds Bill, myself and some great friends in the business have already pledged, is giving pancreatic cancer patients real hope. With this cancer there is currently only a 3% chance of survival.

"In the PDT trial this concert is funding, we have hope and expectation that we can dramatically improve the survival odds for patients.”

Proceeds from the concert will also be supporting new trials with PDT for throat cancer and for disfiguring vascular tumours – including birthmarks.

The organisers of the concert hope that that this will also be a catalyst for an increase in public and corporate donations that will speed the launch of other PDT trials for heart and arterial disease, cervical, vulval and penile cancer.

"I am pleased to be asked to support such a vital cause,” says Jeff Beck "Any new breakthrough in cancer treatment should be taken very seriously and we want as many people to know about that as possible.

"The concert is not just going to raise funds to pay for new PDT trials, but will also help raise public awareness.”

Tickets for the show are on presale directly from the main HMV on Oxford Street in London and on general sale from www.hmvtickets.com from 9am on Friday 19th November.